A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome

被引：0
|
作者：
Shapiro, Roman M.
Lazo-Langner, Alejandro
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1706
引用
收藏
页数：3
相关论文
共 50 条
  • [1] 5-azacytidine treatment results in myelodysplastic syndrome
    Bakanay, S. M.
    Karakilic, E.
    Civriz-Bozdag, S.
    Arat, M.
    Ozcan, M.
    Gurman, G.
    Ilhan, O.
    Beksac, M.
    Konuk, N.
    Arslan, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Management of patients after the failure of hypomethylating treatment for myelodysplastic syndrome
    Lee, J. H.
    Lee, J. H.
    Choi, Y.
    Kim, D. Y.
    Lee, K. H.
    Lee, S. M.
    Lee, W. S.
    Joo, Y. D.
    LEUKEMIA RESEARCH, 2013, 37 : S108 - S108
  • [3] Management of Patients After the Failure of Hypomethylating Treatment for Myelodysplastic Syndrome
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Yunsuk
    Kim, Dae-Young
    Lee, Kyoo-Hyung
    Lee, Sang Min
    Lee, Won Sik
    Jung-Lim, Lee
    Joo, Young-Don
    BLOOD, 2012, 120 (21)
  • [4] Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment
    Latagliata, Roberto
    Niscola, Pasquale
    Spiriti, Maria Antonietta Aloe
    Carmosino, Ida
    Cesini, Laura
    Sarlo, Chiara
    Piccioni, Annalina
    Campagna, Alessia
    De Luca, Maria Lucia
    Vozella, Federico
    Campanelli, Melissa
    Mancini, Marco
    Breccia, Massimo
    Avvisati, Giuseppe
    Tafuri, Agostino
    de Fabritiis, Paolo
    Alimena, Giuliana
    Girmenia, Corrado
    BLOOD, 2016, 128 (22)
  • [5] PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING AZACYTIDINE TREATMENT
    Latagliata, R.
    De Angelis, F.
    De Luca, M. L.
    Carmosino, I.
    Vozella, F.
    Montagna, C.
    Romano, A.
    Petrucci, L.
    Salaroli, A.
    Molica, M.
    Colafigli, G.
    Mancini, M.
    Breccia, M.
    Alimena, G.
    Girmenia, C.
    HAEMATOLOGICA, 2015, 100 : 483 - 484
  • [6] Complete remission of Sweet’s syndrome after azacytidine treatment for concomitant myelodysplastic syndrome
    Sara Martinelli
    Gian Matteo Rigolin
    Genesio Leo
    Roberta Gafà
    Enrico Lista
    Francesca Cibien
    Olga Sofritti
    Giulia Daghia
    Francesco Cavazzini
    Antonio Cuneo
    International Journal of Hematology, 2014, 99 : 663 - 667
  • [7] Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome
    Martinelli, Sara
    Rigolin, Gian Matteo
    Leo, Genesio
    Gafa, Roberta
    Lista, Enrico
    Cibien, Francesca
    Sofritti, Olga
    Daghia, Giulia
    Cavazzini, Francesco
    Cuneo, Antonio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 663 - 667
  • [8] Azacytidine induced localized Sweets syndrome in Myelodysplastic syndrome
    Dev, Tanvi
    Dudani, Pankhuri
    Bhari, Neetu
    DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [9] Azacytidine for the treatment of myelodysplastic syndromes in the elderly
    Campelo M.D.
    Delgado R.G.
    Molias A.C.G.
    Sanchez J.F.
    Advances in Therapy, 2011, 28 (Suppl 2) : 10 - 15
  • [10] Safety and efficacy of 5-azacytidine treatment in myelodysplastic syndrome patients with moderate and mild renal impairment
    Douvali, Evdoxia
    Papoutselis, Menelaos
    Vassilakopoulos, Theodoros P.
    Papadopoulos, Vasileios
    Spanoudakis, Emmanouil
    Tsatalas, Costas
    Kotsianidis, Ioannis
    LEUKEMIA RESEARCH, 2013, 37 (08) : 889 - 893
12345